Search research articles
Contact Us
Filters
Showing results (351-360 of 520) with videos related to
Page
of 52
Sort By:
Cancers
|
July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
Md Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Future Oncology (London, England)
|
September 13, 2019
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
Philip A Philip, Marc E Buyse, Angela T Alistar, et al.
Molecular Cancer Therapeutics
|
October 5, 2007
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
K M Wahidur Rahman, Shadan Ali, Amro Aboukameel, et al.
Cancer
|
July 19, 2006
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer
Howard S Hochster, Daniel G Haller, Aimery de Gramont, et al.
Cancer
|
June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site
Bryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Functional connectivity during drawing after upper extremity peripheral nerve surgery: enhanced connectivity between motor and visuomotor-parietal regions
S Gassass, M D Wheelock, N Kapil, et al.
Cancer
|
September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
Philip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
American Journal of Clinical Oncology
|
April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary
Basil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trials
Philip A Philip, Kari Chansky, Michael LeBlanc, et al.
Nature Reviews. Clinical Oncology
|
March 18, 2023
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Page
of 52
Search research articles
Search
Showing results (351-360 of 520) with videos related to
Sort By:
Page
of 52
Cancers
|
July 2, 2021
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside
Md Hafiz Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, et al.
Future Oncology (London, England)
|
September 13, 2019
A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
Philip A Philip, Marc E Buyse, Angela T Alistar, et al.
Molecular Cancer Therapeutics
|
October 5, 2007
Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
K M Wahidur Rahman, Shadan Ali, Amro Aboukameel, et al.
Cancer
|
July 19, 2006
Consensus report of the international society of gastrointestinal oncology on therapeutic progress in advanced pancreatic cancer
Howard S Hochster, Daniel G Haller, Aimery de Gramont, et al.
Cancer
|
June 28, 2007
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site
Bryan J Schneider, Basil El-Rayes, Jeffery H Muler, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Functional connectivity during drawing after upper extremity peripheral nerve surgery: enhanced connectivity between motor and visuomotor-parietal regions
S Gassass, M D Wheelock, N Kapil, et al.
Cancer
|
September 29, 2011
Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer
Philip A Philip, Michelle R Mahoney, Kyle D Holen, et al.
American Journal of Clinical Oncology
|
April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary
Basil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2014
Historical controls for metastatic pancreatic cancer: benchmarks for planning and analyzing single-arm phase II trials
Philip A Philip, Kari Chansky, Michael LeBlanc, et al.
Nature Reviews. Clinical Oncology
|
March 18, 2023
Neoadjuvant therapy for pancreatic cancer
Christoph Springfeld, Cristina R Ferrone, Matthew H G Katz, et al.
Page
of 52